New: European Medical Agency approves BioNtech/Pfizer vaccine following clinical trials among 40,000 participants, says vaccine meets safety, efficacy and quality standards
Exec dir Emer Cooke says EMA received data right up to the past few days from pharma companies which other regulators (UK + US) would not have received. EMA was "constantly" evaluating evidence + info was "more convincing than anticipated" hence bringing authorisation forward
EMA: no evidence yet that the new strain is susceptible to antibodies generated by vaccine, however there is evidence that the vaccine is capable of generating neutralising antibodies which can neutralise different variants with mutations within the receptor binding domain
Therefore "very likely" the vaccine will retain protection against this new variant
Emer Cooke: Moderna vaccine under evaluation, Jan 6 date for opinion, EMA looking at 47 vaccines under development
• • •
Missing some Tweet in this thread? You can try to
force a refresh
